Neurogene Inc. Total Assets

Quick Answer

Neurogene Inc. reported Total Assets of $288.60 million for the year ending 2025.

  • Neurogene Inc. showed a decrease of -14.0% in Total Assets from 2024 to 2025.
  • This data is from Neurogene Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: $56.45 million | Q2 2014: $52.96 million | Q3 2014: $48.62 million | Q1 2015: $35.13 million | Q2 2015: $29.86 million | Q3 2015: $118.03 million | Q1 2016: $108.21 million | Q2 2016: $100.70 million | Q3 2016: $164.07 million | Q1 2017: $143.33 million | Q2 2017: $133.28 million | Q3 2017: $121.60 million | Q1 2018: $95.62 million | Q2 2018: $104.43 million | Q3 2018: $87.81 million | Q1 2019: $75.43 million | Q2 2019: $73.74 million | Q3 2019: $69.79 million | Q1 2020: $153.05 million | Q2 2020: $145.32 million | Q3 2020: $221.69 million | Q1 2021: $200.10 million | Q2 2021: $187.02 million | Q3 2021: $175.93 million | Q1 2022: $149.13 million | Q2 2022: $137.02 million | Q3 2022: $126.58 million | Q1 2023: $98.46 million | Q2 2023: $94.01 million | Q3 2023: $89.59 million | Q1 2024: $195.35 million | Q2 2024: $179.82 million | Q3 2024: $164.12 million | Q1 2025: $315.30 million | Q2 2025: $297.32 million | Q3 2025: $287.83 million.
  • Over the full 13 years of available data (2013 to 2025), Neurogene Inc.'s Total Assets has grown by 1,744.2%.
  • Historical annual values: Fiscal year 2025: $288.60 million | Fiscal year 2024: $335.73 million | Fiscal year 2023: $222.57 million | Fiscal year 2022: $109.27 million | Fiscal year 2021: $163.26 million | Fiscal year 2020: $210.52 million | Fiscal year 2019: $147.02 million | Fiscal year 2018: $77.62 million | Fiscal year 2017: $110.33 million | Fiscal year 2016: $154.38 million | Fiscal year 2015: $113.34 million | Fiscal year 2014: $41.42 million | Fiscal year 2013: $15.65 million.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: